Wednesday 11 October 2017

Computerized physician/provider order entry (CPOE) market Expected to reach USD 1.9 billion by 2024 : Grand View Research,Inc.

The global computerized physician/provider order entry (CPOE) market is expected to reach USD 1.9 billion by 2024, according to a new report by Grand View Research, Inc. Government and other independent healthcare organizations are striving to streamline care delivery process with the prime objectives of bringing automation, reducing errors, and bringing an overall reduction in clinical decision time especially in the developed economies. CPOE provides a viable platform to support aforementioned objectives. Hence, promotion by government agencies as well as healthcare organizations is spurring the growth of the CPOE market. In addition, increasing incidence of medication errors, caused by poor legibility, communication, and patient misuse, favor the implementation of CPOE. Furthermore, consistent influx of technologically advanced systems such as integrated CPOE with added benefits such as inventory management and easy documentation, act as a vital driver of CPOE market growth.
Browse full report by Grand View Research :
Further Key Findings from the Study Suggest:
·         The computerized physician order entry (CPOE) services sub-segment dominated the component segment in 2015. Enhanced outsourcing of several services coupled with increasing involvement of the professional skills contributed to their growth as compared to CPOE hardware and software sub-segments. Moreover, outsourcing renders increased process efficiency along with development of core competencies and reduced costs.
·         Integrated CPOE systems held a substantial share of more than 70.0% in 2015. Also, this segment is projected to witness lucrative growth over the forecast period, which can be attributed to their competent connectivity across various functionalities such as nursing, pharmacy, and procurement. 
·         Web-based deployment delivery mode segment witnessed highest demand in 2015, increasing penetration of internet services and augmented digital literacy contributed to emergent demand for these services. 
·         On the other hand, cloud-based delivery systems are anticipated to gain substantial market share over the forecast period.  These systems are facilitated with features such as remote data access and data security which render a competitive edge over other systems. 
·         Hospitals led the end-use segment and are also expected to witness lucrative growth in the next 8 years. Greater volume of patients as compared to other end users is the prime factor responsible for high preference of hospitals thereby driving the market growth.  
·         North America, especially the U.S., with its advanced healthcare systems and early adoption of several advanced technologies held a commanding share of more than 50.0% in the global CPOE market. Availability of supportive infrastructure and presence of leading market players in this region positively influenced this region’s growth. 
·         Asia Pacific is projected to grow with a sturdy rate over the forecast period. Large target population base coupled with increasing preference for advanced technological platforms and high unmet needs present market players with the opportunity to invest in this region. 
·         Some of the key players in this market include IBM, Oracle Corporation, SAS, Cerner Corporation, Allscripts, OptumHealth, and Verisk. The notable initiatives in the industry include new product launches, collaboration with government bodies, and investments in R&D. 
Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/healthcare-it
Grand View Research has segmented the global CPOE market on the basis of types, component, delivery mode, end use, and region:
Global CPOE Market by Type (USD Million), 2013 - 2024
·         Integrated
·         Standalone
Global CPOE Market by Component (USD Million), 2013 - 2024
·         Software
·         Hardware
·         Services
Global CPOE Market by Delivery Mode (USD Million), 2013 - 2024
·         On-Premises
·         Web Based
·         Cloud Based
Global CPOE Market by End Use (USD Million), 2013 - 2024
·         Hospital
·         Ambulatory Centers
·         Physician’s Office
·         Emergency Healthcare Centers
CPOE Market by Region (USD Million), 2013 - 2024
·         North America
o    U.S.
o    Canada
·         Europe
o    UK
o    Germany
·         Asia Pacific
o    Japan
o    China
·         Latin America
o    Brazil
o    Mexico
·         MEA
o    South Africa
o    Saudi Arabia

View press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-computerized-physician-order-entry-cpoe-market
About Grand View Research 
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com





Tuesday 10 October 2017

Point of care molecular diagnostics market anticipated to reach USD 3.9 billion by 2024 : Grand View Research,Inc.

Global point of care molecular diagnostics market is anticipated to reach USD 3.9 billion by 2024, according to a new report by Grand View Research, Inc. Ongoing research & development to miniaturize molecular diagnostics testing that provides enhanced near patient testing with high accuracy & lesser turnaround times are major factors expected to reinforce the high growth potential for POC MDx products.
Growing demand for CLIA tests that are, by definition, portable and safe enough to be used in non-laboratory settings such as pharmacy clinics, physician offices, and home-care settings, is expected to drive demand in the market over the forecast period. Ongoing research and development is continually supported and funded by a number of major international entities including the national governments of developed countries and high-value private funding agencies such as the Bill & Melinda Gates Foundation.
Furthermore, a growing portfolio of point-of-care testing capabilities that, had initially been focused on screening, testing, and diagnosis of infectious diseases in low-income developing countries, has been developing at a rapid pace over the past decade to expand its potential market to a broader range of medical faculties. Consequently, POC and molecular diagnosis tests are available and/or are under development for cardiology monitoring, oncology testing, and hematology testing.
Recent advances in the development of microfluidics and genetic sequencing instrumentation pave the way for development of cost-effective, highly accurate and rapid testing platforms, which are able to be used as true POC systems. This is a key factor that significantly contributes towards the favorably funded, high growth potential environment prevalent in the point of care molecular diagnostics market.
Browse full report by Grand View Research :
Further key findings from the report suggest:
·         Application of POC MDx tests for infectious diseases accounted for over 45% of market revenue in 2015. The large share can be accounted for by the presence of an extensive portfolio of the concerned tests with a number of major market entities. Furthermore, growing disease burden of infectious diseases in developing as well as developed countries is another factor the reinforces the dominance of this segment.
·         PCR-based POC tests accounted for the largest share of the market in 2015. Widespread usage of PCR-based techniques for molecular diagnosis and commercialization of POC real time PCR products such as the cobas LIAT by Roche have provided this segment with ample opportunities for revenue generation and are expected to maintain a favorable market environment over the forecast period.
·         North America was observed to be the most lucrative region on this market and estimated to account for over 40% of the global revenue. presence of a technologically advanced medical framework, sophisticated insurance & copayment system & high R&D investment by governments and private funding organizations for the development of POC MDx tests are major factors responsible for the region’s dominant market position.
·         Key players operating in this industry include Johnson & Johnson, Danaher Corp., Cepheid, Bio-Rad Laboratories, bioMerieux, Becton Dickinson, Roche Diagnostics, Bayer Healthcare, Alere Inc (Abbott), Abbott Laboratories among others.
Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/clinical-diagnostics
Grand View Research has segmented point of care molecular diagnostics market on the basis of workflow, mode, services, and region:
Global Point of Care Molecular Diagnostics Application Outlook (Revenue, USD Million, 2013 - 2024)
·         Infectious Diseases
·         Oncology
·         Hematology
·         Prenatal Testing
·         Endocrinology
·         Other Applications
Global Point of Care Molecular Diagnostics Technology Outlook (Revenue, USD Million, 2013 - 2024)
·         PCR-based
·         Genetic Sequencing-based
·         Hybridization-based
·         Microarray-based
Global Point of Care Molecular Diagnostics Test Location Outlook (Revenue, USD Million, 2013 - 2024)
·         OTC
·         POC
Global Point of Care Molecular Diagnostics End-use Outlook (Revenue, USD Million, 2013 - 2024)
·         Decentralized Labs
·         Hospitals
·         Home-care
·         Assisted Living Healthcare Facilities
·         Other uses
Point of Care Molecular Diagnostics Regional Outlook (Revenue, USD Million, 2013 - 2024)
·         North America
o    U.S.
o    Canada
·         Europe
o    Germany
o    UK
·         Asia Pacific
o    China
o    Japan
·         Latin America
o    Brazil
·         MEA
o    South Africa

View press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-point-of-care-poc-molecular-diagnostics-market

About Grand View Research 
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com


XPS (X-ray photoelectron spectroscopy) market Expected to reach USD 712.4 million by 2022 : Grand View Research,Inc.

Global XPS (X-ray photoelectron spectroscopy) market is expected to reach USD 712.4 million by 2022, according to a new study by Grand View Research Inc. Growing application of XPS technology in different industries such as healthcare, semi conductors, aerospace, automotives, and electronics along with rising demand for research and development across all these industries is expected to drive the XPS market over the forecast period. In addition, rising popularity of hyphenated technologies and other technological advancements such as hard X-ray photoelectron spectroscopy (HAXPES) has prompted the growth of the X-ray photoelectron spectroscopy market. The ability of XPS to accurately identify contamination in the provided sample is also expected to contribute towards boosting usage rates. 
Rising demand for XPS technique for drug safety and medical research is expected to serve the market as a future growth opportunity. Presence of supportive government initiatives such as the “Safe Use Initiative” by FDA and “Drug Safety Information Survey” introduced by Health Canada for creating awareness regarding medical research and development are some notable examples likely to provide manufacturers with lucrative growth opportunities. 
Browse full report by Grand View Research :
Further key findings from the study suggest:
·         Element detection is identified as the most lucrative usage segment of the XPS market. Growing demand for hyphenated technologies, presence of extensive R&D conducted by pharmaceutical, semiconductors, electronics, and biotechnological companies are some factors expected to drive segment growth.
·         Contamination detection is also expected to gain significant market share over the forecast period owing to its growing demand in applications involving drug safety and semi conductors.
·         North America accounted for a share of over 40.0% in 2014 majorly on account of the presence of high demand for technologically advanced systems. Rising awareness levels of patients regarding their health, food and environment is also expected to boost regional market growth.
·         Asia Pacific is identified as the fastest growing regional market. Presence of large unmet needs, introduction of suitable government initiatives to increase awareness levels and improving business environments in emerging economies such as China and India are some factors attributing to the region’s high market attractiveness.
·         Key players of this market include Thermo Fisher Scientific, Kratos Analytical, V G Scienta, Evans Analytical Group, Intertek, Yokogawa, Kett and Mitsubishi Electric.
·         Industry rivalry levels of the XPS market is expected to remain at a moderate level over the forecast period. Market players also engage in acquisition and consolidation exercises in an attempt to enhance product portfolio and geographic presence. 
Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the global XPS market on the basis of usage, application and region:
Global XPS Usage Outlook (Revenue, USD Million, 2012 - 2022)
·         Element Detection
·         Contamination Detection
·         Density Estimation
·         Empirical Formula Determination
Global XPS Application Outlook (Revenue, USD Million, 2012 - 2022)
·         Healthcare
·         Semiconductors
·         Electronics
·         Aerospace
·         Automotives
·         Others
Global XPS Healthcare Application Outlook (Revenue, USD Million, 2012 - 2022)
·         Printing
·         Packaging
·         Others
XPS Regional Outlook (Market Revenue in USD Million, 2012 - 2022)
·         North America
o    U.S.
o    Canada
·         Europe
o    UK
o    Germany
o    France
o    Rest of Europe
·         Asia Pacific
o    Japan
o    China
o    India
o    Rest of Asia Pacific
·         Latin America
o    Brazil
o    Mexico
o    Rest of Latin America
·         Middle East and Africa
o    South Africa
o    Rest of Middle East and Africa
View press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-xps-market

About Grand View Research 
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com